Oct 26, 2024 · CDC recommends pneumococcal vaccination for children younger than 5 years and adults 50 years or older. CDC also recommends pneumococcal vaccination for children and adults at …

May 29, 2025 · Download and print official up-to-date PCV (pneumococcal conjugate) VISs in English and Spanish. PDF format.

Feb 16, 2025 · Both the PCV and PPSV vaccines are safe. As with any medicine, there's always the possibility of a serious problem, such as an allergic reaction. But the risk of serious harm or death is …

Mar 5, 2025 · Adults aged 19-49 who have underlying conditions that increase their risk for pneumococcal disease also should receive PCV.

CAPVAXIVE (PCV21) is a 21-valent conjugate pneumococcal vaccine, of purified capsular polysaccharides from 21 serotypes (ST) of Streptococcus pneumoniae, which induces an immune …

Infants and young children usually need 4 doses of pneumococcal conjugate vaccine (PCV15 or PCV20), at ages 2 months, 4 months, 6 months, and 12–15 months. Children 24–59 months of age …

May 29, 2025 · Your health care provider can help you determine which type of PCV, and how many doses, should be received. Infants and young children usually need 4 doses of PCV.

The US Food and Drug Administration (FDA) in June 2024 approved the use of a 21-valent pneumococcal conjugate vaccine (PCV21; Capvaxive) for adults 18 years and older to prevent …

Jun 4, 2025 · Your health care provider can help you determine which type of PCV, and how many doses, should be received. Infants and young children usually need 4 doses of PCV.

Nov 20, 2025 · The 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for more than a decade for older adults and individuals with chronic medical or immunocompromising …